Pavulon   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Pavulon

**Pavulon (Pancuronium)**  
Popular for heart and other really long cases.  
**Class:** Long Acting Neuromuscular Blocking Agent  
**Subclass:** Bisquaternary Aminosteroid  
**Doses:**  
**ED95:** 0.06-0.07mg/kg  
0.08-0.12mg/kg  
**Standard Intubating dose:** 0.1mg/kg  
Re-dose: 0.02mg/kg **Onset:** 3-5 minutes  
**Peak:** 3-5 minutes  
**Duration:** 60-90 minutes  
**Excretion:** Renal 60-80%, Hepatic 15-40%  
Avoid with renal and liver patients.  
**Histamine Release:** None  
**Indications:** Long cases, mostly hearts.  
**Adverse Effects:** Cardiac  
It has atropine like effect to only cardiac muscarinic receptors and activation of SNS. This may increased HR, MAP and CO by 10 to 15% from a selective cardiac vagal blockade.  
Can cause a release NE from adrenergic nerve endings.

#### Copyright Â© 2013